AVITA Medical, Inc. (RCEL) Short term Debt (2025 - 2026)

AVITA Medical (RCEL) has reported Short term Debt for 2 consecutive years, with $46.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Short term Debt rose 1455.3% year-over-year to $46.7 million; the trailing twelve-month figure through Jun 2026 stood at $46.7 million (up 1455.3% YoY), and the FY2025 full-year result was $43.0 million, changed N/A from the prior year.
• Short term Debt rose to $46.7 million in Q2 2026 per RCEL's latest filing, from $43.0 million in the prior quarter.
• Across five years, Short term Debt topped out at $46.7 million in Q2 2026 and bottomed at $3.0 million in Q1 2025.